Table 1.
Baseline patient characteristics.
| Total (n = 199) | |
|---|---|
| Age (years) | |
| Median (range) | 60 (33–79) |
| <65 years | 144 (72.4%) |
| ⩾65 years | 55 (27.6%) |
| Sex | |
| Male | 124 (62.3%) |
| Female | 75 (37.7%) |
| Primary tumor site | |
| Head/Uncinate | 119 (59.8%) |
| Body/Tail | 74 (37.2%) |
| Multifocal | 6 (3.0%) |
| ECOG performance status | |
| 0–1 | 197 (99.0%) |
| Baseline serum CA 19-9 level | |
| Within normal range | 62 (31.2%) |
| Elevated | 137 (68.8%) |
| Median (range), U/mL | 126 (0.6–125000.0) |
| Disease extent by blinded central review | |
| Borderline resectable | 75 (37.7%) |
| Locally advanced unresectable | 124 (62.3%) |
ECOG, Eastern Cooperative Oncology Group.